Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-09-001987
Filing Date
2009-02-17
Accepted
2009-02-17 15:19:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOC ONE filing.txt SC 13G/A 6587
  Complete submission text file 0000315066-09-001987.txt   8581
Mailing Address 82 DEVONSHIRE STREET BOSTON MA 02109
Business Address 82 DEVONSHIRE ST BOSTON MA 02109 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 061209781 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83422 | Film No.: 09612442
SIC: 2834 Pharmaceutical Preparations